Trueblue (TBI) Proxy filing summary

Executive summary

• The annual meeting is scheduled for May 11, 2026, and will be held virtually, with shareholders able to vote online, by mail, or during the meeting.

• The company reported $1.6B in 2025 revenue, completed a major reorganization, and expanded into healthcare staffing through acquisition.

• Technology advancements included AI-powered job matching and predictive analytics across digital platforms.

• The company was recognized as one of the 2026 World's Most Ethical Companies, reinforcing its commitment to ethical leadership.

Voting matters and shareholder proposals

• Shareholders will vote on four proposals: election of nine directors, advisory approval of executive compensation, approval of the amended 2016 Omnibus Incentive Plan, and ratification of Deloitte & Touche LLP as auditor.

• The board recommends a vote FOR all proposals.

• Shareholder proposals and nominations for the 2027 meeting must be submitted between January 11 and February 10, 2027.

Board of directors and corporate governance

• The board consists of nine nominees, eight of whom are independent, with a focus on diversity and relevant industry experience.

• Board refreshment accelerated in 2025, adding two new directors and reducing average tenure to less than five years.

• All directors are elected annually by majority vote, and the roles of CEO and Board Chair are separated.

• Committees (Audit, Compensation, Governance) are composed solely of independent directors.

• Board and committee evaluations are conducted annually, with feedback used to enhance governance practices.